ES2136799T3 - Benzotiofenos de glucopiranosido. - Google Patents

Benzotiofenos de glucopiranosido.

Info

Publication number
ES2136799T3
ES2136799T3 ES95303265T ES95303265T ES2136799T3 ES 2136799 T3 ES2136799 T3 ES 2136799T3 ES 95303265 T ES95303265 T ES 95303265T ES 95303265 T ES95303265 T ES 95303265T ES 2136799 T3 ES2136799 T3 ES 2136799T3
Authority
ES
Spain
Prior art keywords
benzotiofen
glucopyranoside
same
solvate
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95303265T
Other languages
English (en)
Inventor
Jeffrey Alan Dodge
Charles Alan Frolik
Terry Donald Lindstrom
Charles Willis Lugar Iii
Gilbert Stanley Staten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2136799T3 publication Critical patent/ES2136799T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Networks Using Active Elements (AREA)
  • Photoreceptors In Electrophotography (AREA)

Abstract

SE PRESENTA UN COMPUESTO DE LA FORMULA (IA) O (IB) O UNA SAL FARMACOLOGICAMENTE ACEPTABLE O UN SOLVATO DEL MISMO, TAMBIEN SE SUMINISTRAN METODOS DE USO DE LOS COMPUESTOS ANTERIORES, Y PROCESOS PARA LA PREPARACION DE LOS MISMOS.
ES95303265T 1994-05-20 1995-05-16 Benzotiofenos de glucopiranosido. Expired - Lifetime ES2136799T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24665594A 1994-05-20 1994-05-20

Publications (1)

Publication Number Publication Date
ES2136799T3 true ES2136799T3 (es) 1999-12-01

Family

ID=22931623

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95303265T Expired - Lifetime ES2136799T3 (es) 1994-05-20 1995-05-16 Benzotiofenos de glucopiranosido.

Country Status (27)

Country Link
US (2) US5567820A (es)
EP (1) EP0683170B1 (es)
JP (1) JPH07316180A (es)
KR (1) KR950032183A (es)
CN (1) CN1039013C (es)
AT (1) ATE184880T1 (es)
AU (1) AU683734B2 (es)
BR (1) BR9502079A (es)
CA (1) CA2149501A1 (es)
CO (1) CO4650137A1 (es)
CZ (1) CZ126295A3 (es)
DE (1) DE69512310T2 (es)
DK (1) DK0683170T3 (es)
ES (1) ES2136799T3 (es)
FI (1) FI952420L (es)
GR (1) GR3032142T3 (es)
HU (1) HU219335B (es)
IL (1) IL113780A (es)
NO (1) NO304694B1 (es)
NZ (1) NZ272131A (es)
PE (1) PE23396A1 (es)
PL (1) PL308635A1 (es)
RU (1) RU95107655A (es)
SI (1) SI0683170T1 (es)
TW (1) TW323285B (es)
YU (1) YU31995A (es)
ZA (1) ZA953975B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10513470A (ja) * 1995-02-06 1998-12-22 イーライ・リリー・アンド・カンパニー Ｉｌ−６の効果を阻害する方法
US20040167080A1 (en) * 1995-03-15 2004-08-26 Dodge Jeffrey A. Glucopyranoside benzothiophenes
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
UA57596C2 (uk) * 1996-03-26 2003-06-16 Елі Ліллі Енд Компані Похідне бензотіофену, фармацевтична лікарська форма, фармацевтична композиція, спосіб лікування остеопорозу та спосіб зниження рівнів ліпідів
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
EP1212335B1 (en) * 1999-09-13 2006-01-18 Wyeth Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
AU7673900A (en) * 1999-10-08 2001-04-23 Strakan Limited Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof
WO2001027127A1 (en) * 1999-10-08 2001-04-19 Strakan Group Plc Tamoxifen and tamoxifen analogue glycosides and uses thereof
WO2011029088A2 (en) * 2009-09-07 2011-03-10 Dr. Reddy's Laboratories Ltd. Preparation of raloxifene and its salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
SI0683170T1 (en) 2000-02-29
DK0683170T3 (da) 1999-12-20
AU683734B2 (en) 1997-11-20
CZ126295A3 (en) 1995-12-13
CN1039013C (zh) 1998-07-08
EP0683170A1 (en) 1995-11-22
NO951954L (no) 1995-11-21
FI952420A0 (fi) 1995-05-18
US5567820A (en) 1996-10-22
KR950032183A (ko) 1995-12-20
JPH07316180A (ja) 1995-12-05
HU219335B (en) 2001-03-28
EP0683170B1 (en) 1999-09-22
YU31995A (sh) 1998-12-23
DE69512310D1 (de) 1999-10-28
RU95107655A (ru) 1997-02-10
FI952420A7 (fi) 1995-11-21
AU2012195A (en) 1995-11-30
CN1116626A (zh) 1996-02-14
BR9502079A (pt) 1996-03-05
IL113780A0 (en) 1995-08-31
CA2149501A1 (en) 1995-11-21
US6723739B1 (en) 2004-04-20
CO4650137A1 (es) 1998-09-03
PL308635A1 (en) 1995-11-27
DE69512310T2 (de) 2000-02-03
IL113780A (en) 1999-06-20
FI952420L (fi) 1995-11-21
NO951954D0 (no) 1995-05-18
NZ272131A (en) 1996-11-26
ZA953975B (en) 1996-11-18
NO304694B1 (no) 1999-02-01
ATE184880T1 (de) 1999-10-15
GR3032142T3 (en) 2000-04-27
HUT73788A (en) 1996-09-30
TW323285B (es) 1997-12-21
PE23396A1 (es) 1996-06-15
HU9501466D0 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
RU94036004A (ru) Промежуточные соединения для получения ароматических аминоспиртовых производных
FI931368A0 (fi) Tvaettmedelskompositioner, som innehaoller anjoniska ytaktiva aemnen, polyhydroxifettsyraamider och magnesium
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
FI921351L (fi) Laktonpolymerisation som katalyserats med yttrium och saellsynta jordmetalloxidfoereningar.
ES2100151T3 (es) Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos.
FI932659L (fi) Gallsyraderivat, foerfaranden foer deras framstaellning och anvaendning avdessa foereningar som laekemedel
FI951901L (fi) Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
FI931250L (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE8904298D0 (sv) New compounds
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
AR231987A1 (es) Procedimiento para preparar derivados farmaceuticos de pirrolo-2,1-c 1,4 tiazepin-1,5-diona y compuesto intermediario para uso exclusivo en el mismo
AR002157A1 (es) Uso de una dosis inmunizante eficaz de esporozoitos o merozoitos de eimeria vivos, o una mezcla de los mismos
DK345588D0 (da) 1,2-diketo-derivater til anvendelse som renin-inhibitorer
FI913201A7 (fi) Ymppolysackarider, deras framställningsförfarande och deras användning som sekvesteringsagenter
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
FI922186A7 (fi) Limaa muodostavien mikro-organismien torjuminen
FI923841A7 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DK112988D0 (da) Rnase l inhibitor som markoer for virusinfektioner
FI921863A0 (fi) 2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas.
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
SE8302751L (sv) 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem
ATE200291T1 (de) Cephemderivate
MX9200874A (es) Compuestos de una composicion especifica, un procedimiento para su produccion y su uso.
ITTO910353A1 (it) Composti triciclici, procedimento per la loro preparazione

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 683170

Country of ref document: ES